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s observed previously, tetraspanin palmitoyla-
tion promotes tetraspanin microdomain assem-
bly. Here, we show that palmitoylated integrins
(
 
 
 
3, 
 
 
 
6, and 
 
 
 
4 subunits) and tetraspanins (CD9, CD81,
and CD63) coexist in substantially overlapping complexes.
Removal of 
 
 
 
4 palmitoylation sites markedly impaired
cell spreading and signaling through p130Cas on laminin
substrate. Also in palmitoylation-deﬁcient 
 
 
 
4, secondary
associations with tetraspanins (CD9, CD81, and CD63)
were diminished and cell surface CD9 clustering was
decreased, whereas core 
 
 
 
6
 
 
 
4–CD151 complex forma-
tion was unaltered. There is also a functional connection
A
 
between CD9 and 
 
 
 
4 integrins, as evidenced by anti-
CD9 antibody effects on 
 
 
 
4-dependent cell spreading.
Notably, 
 
 
 
4 palmitoylation neither increased localization
into “light membrane” fractions of sucrose gradients nor
decreased solubility in nonionic detergents—hence it
does not promote lipid raft association. Instead, palmi-
toylation of 
 
 
 
4 (and of the closely associated tetraspanin
CD151) promotes CD151–
 
 
 
6
 
 
 
4 incorporation into a
network of secondary tetraspanin interactions (with CD9,
CD81, CD63, etc.), which provides a novel framework
for functional regulation.
 
Introduction
 
The 
 
 
 
6
 
 
 
4 integrin appears on epithelial and other types of
cells, acts as a receptor for basement membrane laminin-5 and
related laminin isoforms, and plays a key role during cell mi-
gration and tumorigenesis (Belkin and Stepp, 2000; Mercurio
et al., 2001). In response to EGF receptor (EGFR) stimulation,
 
 
 
6
 
 
 
4 disconnects from the intermediate filament cytoskeleton
and becomes associated with the actin cytoskeleton in lamelli-
podia and membrane ruffles (Mercurio et al., 2001). During
this process, EGFR signaling might activate the Src family kinase
fyn, leading to phosphorylation of 
 
 
 
4 on tyrosine (Mainiero et
al., 1996; Mariotti et al., 2001), or might activate conventional
PKC, leading to 
 
 
 
4 phosphorylation on serine (Rabinovitz
et al., 1999). Consistent with cooperative signaling between
 
 
 
6
 
 
 
4 and growth factor receptors, 
 
 
 
6
 
 
 
4 has been suggested to
physically associate with fyn (Mariotti et al., 2001), EGFR
(Mariotti et al., 2001), ErbB2 (Gambaletta et al., 2000; Hinter-
mann et al., 2001), c-met (Trusolino et al., 2001), and Ron
(Santoro et al., 2003).
The laminin-binding integrins (
 
 
 
6
 
 
 
4, 
 
 
 
3
 
 
 
1, 
 
 
 
6
 
 
 
1, and
 
 
 
7
 
 
 
1) not only form a distinct subgroup among integrins in
terms of amino acid sequence similarity, but also show ro-
bust association with tetraspanin proteins (Hemler, 1998; Ber-
ditchevski, 2001). There are 32 mammalian tetraspanins, and at
least a few of these are abundantly present on nearly all cell and
tissue types. Tetraspanin proteins regulate cell motility, mor-
phology, fusion, and signaling in the brain and immune system,
on tumors, and elsewhere (Levy et al., 1998; Boucheix and Ru-
binstein, 2001; Hemler, 2001; Stipp et al., 2003b). Tetraspanins
CD151, CD81, and CD9 can modulate 
 
 
 
3
 
 
 
1 and 
 
 
 
6
 
 
 
1 integrin–
dependent neurite outgrowth, cell migration, and/or cell mor-
phology (Yánez-Mó et al., 1998; Yauch et al., 1998; Stipp
and Hemler, 2000; Kazarov et al., 2002; Zhang et al., 2002).
Of particular relevance here, CD151 associates with 
 
 
 
6
 
 
 
4 to
regulate kidney epithelial cell morphology (Yang et al., 2002),
whereas CD9–
 
 
 
6
 
 
 
4 complexes may affect primary keratino-
cyte cell motility (Jones et al., 1996; Baudoux et al., 2000).
Associations of tetraspanins with each other are at least
partly stabilized by palmitoylation. Mutation of CD9 palmi-
toylation sites impaired associations with tetraspanins CD81
and CD53 (Charrin et al., 2002), and loss of CD151 palmi-
toylation decreased association with other tetraspanins (CD81,
CD63, and CD9), without affecting integrin 
 
 
 
3
 
 
 
1 association
(Berditchevski et al., 2002; Yang et al., 2002). Palmitoylation
of CD151 contributes to cell signaling (Berditchevski et al.,
2002). In some proteins (e.g., G proteins and Src family kinases),
palmitoylation leads to the diminished detergent solubility and
lower protein density characteristic of lipid raft association
(Dunphy and Linder, 1998; Resh, 1999). However, palmitoylation
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of tetraspanins CD9 and CD151 causes neither decreased
protein density in sucrose gradients nor decreased detergent
solubility (Berditchevski et al., 2002; Charrin et al., 2002;
Yang et al., 2002).
The 
 
 
 
6
 
 
 
4 integrin, like other laminin-binding integrins,
associates strongly with CD151 (Sterk et al., 2000, 2002).
CD151 association with laminin-binding integrins is direct, oc-
curs early in biosynthesis, and is resistant to disruption by non-
ionic detergents (Yauch et al., 2000; Berditchevski et al., 2001;
Kazarov et al., 2002). Removal of CD151 palmitoylation sites
did not disrupt the CD151–
 
 
 
6
 
 
 
4 complex in epithelial cells,
but did strongly influence 
 
 
 
6
 
 
 
4 integrin–dependent cell mor-
phology (Yang et al., 2002). In contrast to the primary (i.e., di-
rect) associations of 
 
 
 
3 and 
 
 
 
6 integrins with CD151, there is
an extended network of secondary (i.e., most likely indirect)
associations with other tetraspanins (e.g., CD9, CD81, and
CD63) that occur later in biosynthesis and are more sensitive to
nonionic detergents (Berditchevski et al., 2001; Kazarov et al.,
2002). These secondary-type associations are impaired upon
removal of CD151 or CD9 palmitoylation sites (Berditchevski
et al., 2002; Charrin et al., 2002; Yang et al., 2002).
The integrin 
 
 
 
4 subunit was recently shown also to be
palmitoylated (Gagnoux-Palacios et al., 2003). Here, we pro-
vide evidence for palmitoylation of integrins 
 
 
 
3, 
 
 
 
6, and 
 
 
 
4,
and show striking parallels between 
 
 
 
4 integrin and CD151
palmitoylations, in terms of effects on (1) core complex
(CD151–
 
 
 
6
 
 
 
4) formation, (2) secondary complex formation
(involving CD9, CD81, and CD63), (3) integrin density, (4) in-
tegrin solubility, (5) integrin-dependent cell morphology, and
(6) integrin signaling. Our results are in sharp contrast to previ-
ous suggestions that 
 
 
 
4 palmitoylation promotes lipid raft and
Src family kinase association (Mariotti et al., 2001; Gagnoux-
Palacios et al., 2003). We suggest that integrin palmitoylation
promotes, instead of lipid rafts, assembly of a novel type of sig-
naling platform enriched for palmitoylated tetraspanins.
 
Results
 
A network of palmitoylated integrins and 
palmitoylated tetraspanins
 
While studying palmitoylated CD151 (Yang et al., 2002), we
noticed that it associates with palmitoylated proteins re-
sembling the 
 
 
 
4, 
 
 
 
3, and 
 
 
 
6 integrin subunits (Fig. 1 A,
lanes 3 and 4). [
 
3
 
H]palmitate-labeled integrin subunits from
[
 
3
 
H]palmitate-labeled MDA-MB-231 breast carcinoma cells
were more abundant on the cell surface (Fig. 1 A, lane 3) than
intracellularly (Fig. 1 A, lane 4), and were not present in tet-
raspanin CD82 immunoprecipitations (Fig. 1 A, lanes 1 and
2). Integrin palmitoylation was confirmed by recovery of
[
 
3
 
H]palmitate-labeled 
 
 
 
3 (Fig. 1 B, lane 5), 
 
 
 
6 (Fig. 1 B,
lanes 6 and 8), and 
 
 
 
4 (Fig. 1 B, lane 6), but not 
 
 
 
2 (Fig. 1 B,
lanes 4 and 7), from stringent detergent (RIPA) lysates of
A431 cells or B12 kidney epithelial cells. In A431 cells, 
 
 
 
2,
 
 
 
3, and 
 
 
 
6 integrin subunits were present at comparable lev-
els, as indicated by cell surface labeling (Fig. 1 B, lanes 1–3),
and in B12 cells, 
 
 
 
2 and 
 
 
 
6 were again at comparable levels
(not depicted).
When A431 cells were pulse labeled with [
 
3
 
H]palmitate,
followed by a 6-h chase, the palmitate label was retained fully
on the 
 
 
 
4 subunit (Fig. 1 C, top left), and almost completely on
CD151 (Fig. 1 C, top right). Blotting of 
 
 
 
6 and 
 
 
 
3 (Fig. 1
C, bottom) revealed similar levels of total 
 
 
 
6
 
 
 
4 and 
 
 
 
3
 
 
 
1–
CD151 complexes throughout the experiment. Palmitoylations
of 
 
 
 
4 and CD151 were almost completely inhibited by a pro-
tein synthesis inhibitor (cycloheximide) and by a Golgi-dis-
rupting agent (brefeldin A) (unpublished data). Hence, CD151
and 
 
 
 
4 palmitoylations both occur early in biosynthesis and
undergo little subsequent turnover.
Results shown in Fig. 1 A suggested that additional
palmitoylated proteins, including CD9, associate with palmi-
toylated CD151 and palmitoylated integrins. Indeed, the pro-
files of palmitoylated proteins associated with tetraspanins
(CD9 and CD151) and integrins (
 
 
 
6
 
 
 
4 and 
 
 
 
3
 
 
 
1) from
MDA-MB-231 cells are strikingly similar (Fig. 2 A). No
[
 
3
 
H]palmitate-labeled proteins associated with 
 
 
 
2 integrin,
which itself is not palmitoylated (Fig. 2 A, lane 1). Palmitoyl-
ated protein profiles for CD9, CD151, 
 
 
 
3
 
 
 
1, and 
 
 
 
6
 
 
 
4 were
similarly congruent in two additional cell lines (MCF-10A
and A431; unpublished data). Immunoprecipitation of CD9,
CD151, 
 
 
 
3, and 
 
 
 
6 from MDA-MB-231 cells (Fig. 2 B) or
MCF-10A cells (Fig. 2 D) yielded, in each case, 
 
 
 
4, 
 
 
 
1, and
Figure 1. Integrin  3,  6, and  4 subunits undergo palmitoylation.
(A) MDA-MB-231 human breast carcinoma cells were pulsed with [
3H]pal-
mitate and incubated at 4 C with mAb anti-CD82 (mAb M104) or anti-
CD151 (mAb 5C11). Unbound antibody was removed, cells were lysed in
1% Brij 96, and immune complexes were collected using protein G–agarose.
Remaining lysate was then used for further immunoprecipitation. In, intracel-
lular fraction; Sur, surface fraction. (B) A431 cells were pulsed with
[
3H]palmitate, surface labeled with biotin, and lysed in RIPA buffer, and
then human  2,  3, and  6 integrins were immunoprecipitated using mAbs
A2-IIE10, A3-X8, and GoH3, respectively. Proteins labeled with biotin
(lanes 1–3) and [
3H]palmitate (lanes 4–6) are shown. Kidney epithelial B12
cells expressing human integrin  2 and  6 were also labeled with
[
3H]palmitate, and then  2 and  6 were immunoprecipitated (lanes 7 and
8). Comparable cell surface  2 and  6 levels were seen by flow cytometry
(not depicted). Note that, under RIPA conditions, human  6 remains associ-
ated with human (lane 6), but not mouse (lane 8)  4. White lines indicate
that intervening lanes have been spliced out. (C) A431 cells were pulsed
with [
3H]palmitate and then chased in the presence of 100  M unlabeled
palmitic acid for up to 6 h, as indicated. Anti- 6 and anti-CD151 immuno-
precipitates were analyzed for [
3H] labeling of  4 and CD151 (top) or by
immunoblotting (loading controls, bottom) using anti- 6 cyto tail antibody
(to evaluate  6 4) and anti- 3 cyto tail antibody (to evaluate  3 1–
CD151 complexes). Question mark indicates unknown protein.INTEGRIN PALMITOYLATION • YANG ET AL. 1233
CD9, as indicated by blotting. Immunoprecipitation of  3,  6,
and CD9 from A431 cells again yielded, in each case, both  4
and  1 (Fig. 2 C). Immunoprecipitation of  2 yielded  1 (as
expected), but not  4 or CD9 (Fig. 2, B and C). Likewise, im-
munoprecipitation of CD147 (a highly expressed control cell
surface protein) did not yield  1,  4, or CD9 (Fig. 2 D). Re-
sults shown in Fig. 2 indicate that complexes containing pal-
mitoylated CD9, CD151,  6 4, and  3 1 are substantially
overlapping in three different cell lines.
Removal of integrin palmitoylation sites
The membrane-proximal region of the  4 cytoplasmic tail
contains seven potential cysteine palmitoylation sites (Fig. 3 A).
Because palmitoylation often occurs on multiple clustered
cysteines in the same molecule (Gundersen et al., 1994; Chap-
man et al., 1996; Berditchevski et al., 2002; Charrin et al.,
2002; Yang et al., 2002), we prepared a “7C/S”  4 mutant, re-
placing all seven cysteines with serines. When stably ex-
pressed in MDA-MB-435 cells, wild-type  4, but not the
7C/S mutant, incorporated [
3H]palmitate (Fig. 3 B, left). Al-
though  4 palmitoylation was lost, the 7C/S mutant retained
association with palmitoylated  6 (Fig. 3 B, left). Wild-type
and mutant  4 were present at similar levels, as detected by
anti- 4 immunoblotting (Fig. 3 B, right; and Fig. 4 B, middle),
flow cytometry (Fig. 4 A), cell surface biotinylation (Fig. 4 B,
top), and by [
35S]methionine labeling (not depicted). Mutant
Figure 2. Palmitoylated integrins associate with each other and with
multiple palmitoylated tetraspanin proteins. (A) MDA-MB-231 cells were
pulsed with [
3H]palmitate, lysed in 1% CHAPS, and then integrins ( 2,
 6, and  3) and tetraspanins (CD9 and CD151) were immunoprecipitated
using mAbs A2-IIE10, GoH3, A3-X8, Du-All, and 5C11, respectively.
Question mark indicates unknown protein. (B) MDA-MB-231 cells were
immunoprecipitated as in A, and then samples were blotted for  4 (rabbit
pAb),  1 (rabbit pAb), and CD9 (C9BB), as indicated. (C) A431 cells
were lysed and immunoprecipitated as in A, and then samples were blotted
for  4 and  1 (as in B). Note that the band in the  2 lanes migrating
slightly below the  4 band (B and C) is an Ig background band, which
does not appear in the  2 lane when [
3H]palmitate labeling is used (A).
(D) Indicated proteins were immunoprecipitated from MCF-10A cells, as in
A, and then blotted as in B. As a negative control, abundant cell surface
protein CD147 was immunoprecipitated using mAb 8G6. White lines
(A and D) indicate that intervening lanes have been spliced out.
Figure 3. Identification of integrin palmitoylation sites. (A) Membrane-
proximal regions containing candidate palmitoylation sites are shaded
gray. The first lysine defines a putative transmembrane interface. A and B
designate alternatively spliced forms of integrin cytoplasmic tails. (B) MDA-
MB-435 cells stably expressing mutant or wild-type  4, or vector control,
were [
3H]palmitate labeled and lysed in 1% Brij 96. The  2 integrin was
immunoprecipitated from vector control cells, and  6 4 was immunopre-
cipitated (using anti- 6 mAb GoH3) from  4-transfected cells. Shown are
proteins labeled with [
3H]palmitate (left) or blotted with anti- 4 antibody
(right). (C) Murine B12 cells, stably expressing human integrin   subunits,
were [
3H]palmitate labeled and lysed in 1% RIPA. Integrins were immuno-
precipitated using anti–human  2 (lane 1) and  3 (lanes 2–5) antibodies
(A2-IIE10 and A3-X8) and resolved by SDS-PAGE, and [
3H]palmitate was
detected. The  3 subunits include  3-X3TC5 ( 3 tail and transmembrane
regions are replaced by those regions from  5; Yauch et al., 1998) and
 3-C1067S (palmitoylation site point mutant).
Figure 4. Comparable expression of wild-type and
mutant  4 in MDA-435 cells. (A) MDA-MB-435 cells
stably expressing vector or wild-type (Wt) or 7C/S  4
were analyzed using anti- 4 (mAb AA3), anti-CD151
(mAb 5C11), anti- 6 (mAb A6-ELE), and anti- 3
(mAb A3-X8). Histograms represent Wt  4 cells (thick
line), 7C/S  4 cells (dashed line), background auto-
fluorescence (dotted line), and vector control cells (thin
line). Data are representative of three independent
experiments. (B) MDA-MB-435 cells stably expressing
vector or Wt or 7C/S  4 were surface labeled with
biotin and lysed in 1% Brij 96, and then the  6 4–
CD151 complex was immunoprecipitated (using anti-
 4 mAb AA3) and analyzed by blotting for biotin-
labeled proteins (avidin blotting; top), total  4 (rabbit
pAb; middle), or CD151 (mAb 1A5; bottom).JCB • VOLUME 167 • NUMBER 6 • 2004 1234
and wild-type  4 associated similarly with their core partner,
CD151 (Fig. 4 B, bottom), and brought similarly elevated
amounts of CD151 and  6 to the cell surface (Fig. 4 A). Lev-
els of cell surface  3 (Fig. 4 A) and  1 (not depicted) also
remained very similar when either wild-type or mutant  4
was expressed.
The membrane-proximal regions of integrin  3,  6, and
 7 cytoplasmic tails contain a single cysteine residue (Fig. 3 A)
that is highly conserved in diverse animal species, but not in
most other integrin   chains. Upon replacement of this key res-
idue in  3 with serine (C1067S mutation), or upon replacement
of the entire  3 cytoplasmic tail and transmembrane with the
tail and transmembrane of  5 (X3TC5), palmitoylation was
completely lost (Fig. 3 C, lanes 4 and 5). In the same experi-
ment, palmitoylation of wild-type human  3A and  3B was
readily observed (Fig. 3 C, lanes 2 and 3). Despite loss of pal-
mitoylation in the C1067S and X3TC5 mutants, these inte-
grins retained association with palmitoylated tetraspanin CD151
(Fig. 3 C, lanes 4 and 5).
Effects of integrin  4 palmitoylation on 
cell functions
We observed comparable hemidesmosome-like staining for
GFP-tagged wild-type and mutant  4 in A431 cells (unpub-
lished data). Because a high level of endogenous  4 pre-
cluded further functional studies in A431 cells, we switched
to MDA-MB-435 cells, with minimal endogenous  4, for
studies of stably expressed wild-type and 7C/S  4. On lami-
nin-5, spreading of 7C/S cells was markedly impaired com-
pared with that of cells with control vector or wild-type  4
(Fig. 5 A, top). All cells spread equally well on vitronectin
(Fig. 5 A, bottom). Quantitation of multiple experiments con-
firmed deficient 7C/S  4 cell spreading on laminin-5 but not
vitronectin substrate (Fig. 5 B). A marked defect in tyrosine
phosphorylation of p130Cas was also observed for 7C/S  4
cells (Fig. 5 C, lanes 7 and 12) compared with wild-type  4
cells (Fig. 5 C, lanes 6 and 11), when plated on laminin-1 or
laminin-5. No defect was seen on control ligand (vitronectin;
Fig. 5 C, lanes 3 and 4), and minimal p130Cas phosphoryla-
tion was seen for cells in suspension (Fig. 5 C, lanes 1 and 2).
In contrast to results with p130Cas, mutant and wild-type  4
showed little difference in phosphorylation of FAK (unpub-
lished data). In concert with cell spreading, p130Cas is typi-
cally phosphorylated by a mechanism dependent on Src fam-
ily kinases (O’Neill et al., 2000). Consistent with this, the Src
family kinase inhibitor PP2 (Hanke et al., 1996) abolished
both p130Cas phosphorylation (see Fig. 7 A, lanes 8–10) and
wild-type  4–MDA-MB-435 cell spreading on laminin-5 (not
depicted). Similar spreading and signaling defects were also
seen for 7C/S  4–transfected SK-MEL-5 melanoma cells (un-
published data).
Figure 5.  4 integrin–mediated cell spreading. (A) MDA-MB-435 cells
stably expressing vector or wild-type (WT) or 7C/S  4 were held in sus-
pension at 37 C for 30 min, and then were plated on wells coated in PBS
at 4 C overnight with either laminin-5 (LN; subpanels A–C) or vitronectin
(VN; subpanels D–E), and photographed after 45 min. Cell spreading
was monitored using a microscope (Axiovert 135; Carl Zeiss MicroImag-
ing, Inc.) as described previously (Stipp and Hemler, 2000). Bar, 50  m.
(B) Cell spreading was estimated by determining the percentage of cells
that were no longer round and phase-bright. The accuracy of this method
was validated by quantitation of cell area using Scion Image software,
which confirmed that we could readily distinguish cells in which the area
had increased by  1.2-fold. Results (mean   SD) are derived from at
least two separate experiments, counting at least two representative fields
in each experiment, with at least 50 cells/field. (C) MDA-MB-435 cells
were suspended at 37 C for 30 min, and then either retained in suspen-
sion or plated on vitronectin (Vn), laminin-1, or laminin-5 for 45 min.
Some samples (lanes 8–10) were preincubated with 1.0  g/ml PP2 in
DMSO for 20 min before plating. Cells were collected and lysed in RIPA,
and p130Cas was immunoprecipitated. After SDS-PAGE, samples were
blotted with antiphosphotyrosine mAb 4G10. To assess protein loading,
the blot was stripped and reblotted with p130Cas-specific antibody. Similar
results were seen in multiple experiments.
Figure 6.  1-dependent cell adhesion is unaffected by  4 mutation.
(A) To assess cell adhesion, MDA-MB-435 cells were plated on specific
substrates for 30 min, and then nonadherent cells were removed by washing
and adherent cells were stained using Wright-Giemsa and then quanti-
tated at OD 590 using an ELISA 96-well plate reader. Starting with
70,000 cells/well,  70% cell adhesion corresponds to OD 590   0.3.
(B) Cells were incubated with  10  g/ml of the indicated mAbs at RT for
15 min before being plated on laminin-5. Adhesion was determined as in A.
(C) Effects of indicated antibodies on adhesion of wild-type (Wt)  4 cells
was determined as in A and B. Results shown are the means of triplicate
determinations   SD.INTEGRIN PALMITOYLATION • YANG ET AL. 1235
The spreading defect does not arise because of diminished
cell adhesion. In a 30-min static cell adhesion assay, all cells ad-
hered similarly to laminin-1, laminin-5, and vitronectin (Fig. 6
A). Adhesion to laminin-5 (Fig. 6 B) or laminin-1 (not depicted)
was dependent on  1 rather than  4 integrins, as indicated by
nearly complete blocking with an anti- 1 monoclonal antibody.
On laminin-1, adhesion was almost entirely  6 1 dependent,
whereas on laminin-5,  3 1 also contributed (Fig. 6 C). On
vitronectin, antibodies to laminin receptors had minimal inhibi-
tory effect. The use of  6 1, but not  6 4, for adhesion is in
accord with a previous study of untransfected and  4-trans-
fected MDA-MB-435 cells (Shaw et al., 1997). Expression lev-
els for  3 1 and  6 1 were essentially unchanged, regardless
of whether mutant or wild-type  4 was present, as seen by flow
cytometry (Fig. 4 A) and immunoblotting (not depicted).
Lipid rafts, growth factor receptors, and 
Src kinases
Palmitoylation diminishes the solubility of some lipid raft–type
proteins, leading to increased appearance in “light membrane”
fractions of sucrose gradients and decreased extractability in non-
ionic detergents (Dunphy and Linder, 1998; Resh, 1999). How-
ever, CD151 palmitoylation neither decreased density in sucrose
gradients nor decreased detergent solubility (Yang et al., 2002).
Similarly, in A431 cells, palmitoylation of  4 (compared with
7C/S  4) did not yield decreased density in sucrose gradients
in either stringent (Triton X-100) or mild (1% Brij 96) deter-
gent conditions (Fig. 7 A). Furthermore, neither endogenous
[
3H]palmitate-labeled  4 nor endogenous  4 cell surface–labeled
with biotin appeared in the low density fractions of a sucrose gra-
dient, even when mild Brij 96 detergent conditions were used
(Fig. 7 B). In control experiments, abundant endogenous caveo-
lin-1 appeared in low density fractions (Fig. 7 B, Fract 1–4) and
transferrin receptor (CD71) marked the dense fractions (Fig. 7 B,
Fract 8–12). Furthermore, in MDA-MB-435 cells, palmitoylated
 4 integrin (compared with the 7C/S mutant) showed increased
solubility in nonionic detergent. Upon extraction of cells with 1%
Brij 96 for 10 or 20 min, the solubility of wild-type  4 protein
was 69% and 82%, respectively, relative to the total extractable
 4 (in RIPA). In marked contrast, the 7C/S mutant remained at
40% solubility at the 10- and 20-min time points, although by 30
min, both mutant and wild-type  4 were completely extracted. In
conclusion, palmitoylation did not endow  4 with lipid raft–like
properties in either A431 or MDA-MB-435 cells.
As mentioned in the Introduction, integrin  4 can associ-
ate with activated EGFR-type growth factor receptors and Src
family kinases. However, in EGF-stimulated A431 cells, we ob-
served no difference in levels of tyrosine-phosphorylated EGFR
associating with GFP-tagged 7C/S and wild-type  4 (Fig. 8 A,
top, lanes 2 and 4). In control experiments, deletion of portions
of the  4 tail did diminish association with tyrosine-phosphory-
lated EGFR (Fig. 8 A, top, lanes 6 and 8) and EGFR protein
(Fig. 8 A, middle, lanes 5–8). Tyrosine-phosphorylated EGFR
was not detected in the absence of EGF stimulation (Fig. 8 A,
top, lanes 1, 3, 5, and 7) or when  4 was not immunoprecipi-
Figure 7. Sucrose density gradient analyses of  4 integrins and integrin–
tetraspanin complexes. (A) A431 cells (expressing either wild-type [Wt] or
7C/S  4–GFP) were lysed in 1% Brij 96 or 1% Triton X-100, and then
fractionated on 5–35–45% discontinuous sucrose density gradients at 4 C
(Claas et al., 2001). 50- l aliquots of total lysate from each fraction were
blotted for  4, using anti-GFP mAb, or for caveolin-1, using rabbit pAb.
(B) Untransfected A431 cells were pulsed with [
3H]palmitate, surface la-
beled with biotin, lysed in 1% Brij 96, and then fractionated as in A. From
each of the 12 fractions, 50  l was used for immunoprecipitation of
CD151 (mAb 5C11), and [
3H] labeling was detected (top), or CD151 was
immunoprecipitated and proteins that were surface labeled with biotin were
detected by avidin blotting (middle). Also, 50- l aliquots of total lysate from
each fraction were blotted for CD71 (transferrin receptor; bottom).
Figure 8.  4 palmitoylation does not affect association with EGFR, fyn,
or ErbB3. (A) A431 cells stably expressing wild-type (Wt) or mutant  4–
GFP proteins were serum-starved for  12 h, stimulated with (or without)
50 ng/ml EGF for 10 min, and lysed in RIPA, and then  4 was immuno-
precipitated using anti-GFP pAb. Samples were blotted for phosphoty-
rosine (mAb 4G10) and  4 (mAb anti-GFP). Del1,  4 deleted after the third
fibronectin repeat (aa 1582); Del2,  4 deleted after the second fibronectin
repeat (aa 1412). (B) Samples were prepared as in A, and then EGFR
and fyn were immunoprecipitated and blotted for phosphotyrosine, using
mAb 4G10. (C) A431 transfectants were stimulated and lysed as in A;
 2,  6, and  4 immunoprecipitations were performed; and samples were
blotted for fyn (using pAb). W, wild-type  4; 7, 7C/S  4. (D) MDA-MB-
435 transfectants were treated with (or without) 100 ng/ml heregulin for
10 min and lysed in RIPA, and then  6 4 was immunoprecipitated using
mAb GoH3. ErbB3 was blotted for phosphotyrosine (top) and  4 was
blotted using anti- 4 pAb (bottom). (E) MDA-MB-435 cell lysate was pre-
pared in D, and ErbB3 was immunoprecipitated. Samples were blotted for
phosphotyrosine, total ErbB3, and p85 subunit of PI 3-K.JCB • VOLUME 167 • NUMBER 6 • 2004 1236
tated (Fig. 8 A, lane 9). Comparable amounts of  4 were recov-
ered in each lane (Fig. 8 A, bottom, lanes 1–8). As expected
(Mariotti et al., 2001), an abundance of tyrosine-phosphorylated
EGFR was recovered in association with the Src family kinase
fyn (Fig. 8 B), but no fyn was recovered in association with ei-
ther mutant or wild-type  4 that had been immunoprecipitated
with antibodies to either  6 or  4 (Fig. 8 C). In addition, there
were no consistent differences in tyrosine phosphorylation
of 7C/S and wild-type  4 (unpublished data). Integrin  6 4
also associates with ErbB2 (Hintermann et al., 2001), which in
MDA-MB-435 cells forms dimers with ErbB3 (Adelsman et al.,
1999). However, after heregulin treatment to induce ErbB phos-
phorylation, we observed no association of either wild-type or
mutant  4 with tyrosine-phosphorylated ErbB3 (Fig. 8 D) or
ErbB2 (not depicted). Also, for mutant  4 in MDA-MB-435
cells, we saw no diminution in ErbB3 tyrosine phosphorylation
or ErbB3 association with the p85 subunit of PI 3-K (Fig. 8 E).
Diminished association with tetraspanins
Removal of CD151 palmitoylation sites did not affect core as-
sociation with  3 1 or  6 4, but did alter secondary associa-
tions with other tetraspanins (Berditchevski et al., 2002; Yang
et al., 2002). Likewise, removal of  4 palmitoylation sites did
not affect core association with CD151 (Fig. 4 B), but did
markedly alter secondary associations with other tetraspanins
(Fig. 9 A). As indicated by immunoprecipitations of  6 or
CD151, association of CD9, cell surface CD9 (sCD9), CD81,
and CD63 was impaired in 7C/S–MDA-MB-435 cells, in five
different experiments. In control experiments, the levels of wild-
type and 7C/S  4 associated with  6 were unaltered, as were the
total levels of CD151, CD9, CD81, and CD63 (Fig. 9 B). Simi-
lar levels of CD63 were seen by flow cytometry (Fig. 9 C, top).
Flow cytometry showed that surface levels of tetraspanin
CD9 were very similar, as indicated by mAb ALB6 staining
(Fig. 9 C, middle), but different as indicated by mAb C9BB
staining (Fig. 9 C, bottom). Indeed, the C9BB/ALB6 staining
ratio (0.59 in wild-type cells) decreased to 0.34 in 7C/S cells.
After  4-transfected MDA-MB-435 cells had been cultured for
a few more months, there was an even larger difference in
C9BB/ALB6 ratios (0.56 in wild-type vs. 0.07 in 7C/S cells),
whereas mutant and wild-type  4 levels remained equal (un-
published data). Wild-type  4–GFP and 7C/S  4–GFP were
expressed in another cell line (SK-MEL-5), and again there
was similar staining of CD9 by mAb ALB6, but selectively di-
minished staining of the mutant cells by mAb C9BB, such that
the C9BB/ALB6 ratio decreased by  40% (unpublished data).
These results indicate that cell surface tetraspanin organization
is affected by  4 palmitoylation.
Functional link between CD9 and  4
In cells where CD9 associates with  6 4, anti-CD9 antibodies
can alter  6 4-dependent cell motility (Jones et al., 1996; Bau-
doux et al., 2000). Here, we confirm a functional connection
between CD9 and laminin-binding integrins in MDA-MB-435
cells. Addition of an anti-CD9 antibody (ALB6) stimulated cell
spreading in 7C/S cells, and to an even greater extent in cells
expressing wild-type  4 (Fig. 10). Background spreading was
observed in the presence of control anti- 2 and anti-CD81 anti-
bodies. As expected from the results shown in Fig. 5, spreading
on laminin-5 was elevated for wild-type  4 cells. The anti-CD9
mAb ALB6 did not promote spreading of either wild-type
(Fig. 10) or 7C/S (not depicted) cells on vitronectin, and had no
effect on static cell adhesion to laminin-1 or laminin-5.
Figure 9. Loss of  4 palmitoylation sites causes tetraspanin reorganization.
(A) MDA-MB-435 cells stably expressing wild-type (Wt) or 7C/S  4 were
surface labeled with biotin and lysed in 1% Brij 96, and then the  6 4–
CD151 complex was immunoprecipitated using anti- 6 mAb GoH3 or anti-
CD151 mAb 5C11. Panels were then blotted for CD9 (mAb C9BB; first and
third panels), cell surface CD9 (avidin blotting; second panel), CD81 (mAb
M38; fourth panel), or CD63 (mAb 6H1; fifth panel). (B) From an anti- 6
immunoprecipitation, surface labeled  4 was detected (avidin blotting; first
panel). CD151 was immunoprecipitated (mAb 5C11) and detected (mAb
1A5; second panel), CD9 was immunoprecipitated (mAb ALB6) and blotted
(mAb C9BB; third panel), CD81 was immunoprecipitated and blotted (mAb
M38; fourth panel), and CD63 was immunoprecipitated and blotted (mAb
6H1; fifth panel). (C) MDA-MB-435 cells stably expressing mock, Wt, or
7C/S  4 were analyzed using anti-CD63 (mAb 6H1) and the indicated
anti-CD9 antibodies. Histograms are from Wt  4 cells (thick line), 7C/S  4
cells (dashed line), and background autofluorescence (dotted line). Data are
representative of three independent experiments.
Figure 10. Anti-CD9 antibody stimulates cell spreading. MDA-MB-435
cells spread on the indicated substrates for 45 min, in the presence of
mAb ALB6 (anti-CD9) or control antibodies (2E10, anti–integrin  2; and
M38, anti-CD81). Spreading was assessed as described in the Fig. 5 legend
(**, P   0.02 vs. controls; *, P   0.06 vs. controls). Error bars indicate
SEM, and dashes indicate that no antibody was added.INTEGRIN PALMITOYLATION • YANG ET AL. 1237
Discussion
CD151 and  4 palmitoylation similarities
There are several striking similarities between  4 and tetraspa-
nin CD151, with respect to palmitoylation. First, multiple
membrane-proximal cysteines are used. Although six cysteines
may contribute to CD151 palmitoylation (Berditchevski et al.,
2002; Yang et al., 2002), removal of seven cysteines eliminated
all detectable [
3H]palmitate incorporation into  4. Removal of
only one, two, three, or five membrane-proximal cysteines
yielded incomplete results (Gagnoux-Palacios et al., 2003).
The seven mutated cysteines are exactly conserved in  4 from
multiple species (e.g., humans, rats, and mice), but do not ap-
pear in any other integrin   subunits. Second, palmitoylation of
both CD151 (Berditchevski et al., 2002; Yang et al., 2002) and
 4 occurs on newly synthesized protein and remains stably at-
tached, with minimal turnover on the mature proteins. Third,
removal of palmitoylation sites from CD151 (Berditchevski et
al., 2002; Yang et al., 2002) or  4 increased neither protein
density nor detergent solubility/extractability (see TEMs and
lipid raft localization section). Fourth, removal of palmitoyla-
tion sites from CD151 (Berditchevski et al., 2002; Yang et al.,
2002) or  4 did not alter static cell adhesion, but did alter
 6 4-dependent cell signaling and morphology. Fifth, immu-
noprecipitation of either CD151 or  6 4 yielded strikingly
similar patterns of palmitoylated proteins. Sixth, loss of palmi-
toylation from either molecule did not disrupt the core CD151–
 6 4 complex. However, seventh, loss of palmitoylation from
either CD151 (Berditchevski et al., 2002; Yang et al., 2002) or
 4 did markedly alter secondary associations with other tet-
raspanins. These observations reinforce the concept that the
CD151– 6 4 core complex is similarly affected by palmitoy-
lation on either CD151 or  4.
Tetraspanin-enriched microdomains 
(TEMs)
It is well established that tetraspanin proteins (including
CD151 and CD9) and their partners associate with each other
in extended complexes known as the tetraspanin web (Truso-
lino et al., 2001), or TEMs (Berditchevski et al., 2002; Hemler,
2003). TEMs contain primary complexes (e.g., CD151–inte-
grin [Serru et al., 1999; Yauch et al., 2000; Kazarov et al.,
2002; Sterk et al., 2002] and tetraspanin homodimers [Kova-
lenko et al., 2004]) occurring through direct, protein–protein
interactions. These are then brought together into extended sec-
ondary complexes, with tetraspanin palmitoylation playing a
key role (Berditchevski et al., 2002; Charrin et al., 2002; Yang
et al., 2002; Hemler, 2003). Given the abundance of evidence
regarding CD151 palmitoylation, and the strong similarities be-
tween CD151 and  4 (see previous section), it is not surprising
that   4 palmitoylation would also contribute to localization
into TEMs. The evidence for this is as follows. First, in multi-
ple cell lines, palmitoylated  4 associates with other palmitoyl-
ated proteins (CD9, CD81, CD63, and others) in a pattern that
is strikingly similar whether immunoprecipitated with antibod-
ies to CD151, to CD9, or to integrins ( 6 4 or  3 1). The
specificity of interaction among these particular components is
emphasized by the exclusion of other abundant cell surface
molecules (e.g., integrin  2 1 and tetraspanin CD82). Consis-
tent with our results, others have also shown that CD9 can as-
sociate with  6 4 (Jones et al., 1996; Baudoux et al., 2000).
Second, loss of  4 palmitoylation diminished secondary asso-
ciations with other tetraspanins (CD9, CD81, and CD63), just
as seen previously upon removal of CD151 and CD9 palmi-
toylation sites (Berditchevski et al., 2002; Charrin et al., 2002;
Yang et al., 2002). Third, not only was CD9 substantially dis-
sociated from the palmitoylation-deficient  6 4–CD151 com-
plex, it also showed reorganization on the cell surface, which is
consistent with reduced clustering. Pairs of monoclonal anti-
bodies, diagnostic for cell surface clustering, have been de-
scribed for other molecules, including CD147 (Koch et al.,
1999) and CDw78 (Drbal et al., 1999). In each case, a lower af-
finity antibody (such as anti-CD9 mAb C9BB) showed more
dependence on bivalent binding, and hence more sensitivity to
cell surface clustering, compared with a higher affinity anti-
body (such as anti-CD9 mAb ALB6).
It is likely not a coincidence that the integrin   subunits
( 3,  6, and  7) best able to interact with tetraspanins also
contain palmitoylation sites. The integrin  3,  6, and  7 sub-
units contain single, membrane-proximal cysteine palmitoyla-
tion sites, conserved in orthologous subunits across a wide
range of animal species. For  3 and  6, the key cysteine is
present in both major ( 3A and  6A) and minor ( 3B and
 6B) alternatively spliced forms. In contrast to the integrin  3,
 6, and  7 subunits, the other 13 integrin   subunits (except
for  E and  8) don’t contain membrane-proximal cysteines.
Functional consequences
Removal of CD151 palmitoylation did not affect static cell ad-
hesion but did alter  6 4-dependent kidney epithelial cell mor-
phology (Yang et al., 2002) and integrin-dependent signaling in
fibroblasts (Berditchevski et al., 2002). Similarly, removal of
 4 palmitoylation did not alter cell surface expression levels,
association with  6 or CD151, or cell adhesion to laminins, but
did alter  6 4-dependent spreading and associated signaling
through p130Cas in MDA-MB-435 cells. Although  4 has not
previously been linked to p130Cas signaling, p130Cas is prefer-
entially activated when cells are plated on laminin, compared
with fibronectin (Gu et al., 2001). Inhibition by the Src family
kinase inhibitor PP2 is consistent with cell spreading depending
on Src family kinase phosphorylation of p130Cas (Nojima
et al., 1996; Panetti, 2002). Presently, we cannot determine
whether impaired cell spreading, due to the absence of  4
palmitoylation, is a consequence or a cause of diminished Src
kinase → p130Cas signaling. Notably, Gagnoux-Palacios et al.
(2003) have also reported altered Src family kinase–dependent
signaling upon removal of  4 palmitoylation sites. Upon re-
moval of palmitoylation from CD151 (Berditchevski et al.,
2002) or  4, signaling through FAK was unaltered, consistent
with cell adhesion being unaltered. Our results are in accord
with previous evidence that FAK and p130Cas can sometimes
be differentially regulated (Gu et al., 2001).
For several reasons, we suggest that  4 palmitoylation–
dependent recruitment of CD151– 6 4 into TEMs plays a ma-JCB • VOLUME 167 • NUMBER 6 • 2004 1238
jor role in determining cell spreading and signaling. First, di-
minished spreading and signaling occurred in parallel with re-
duced secondary associations of  6 4 with tetraspanins (CD9,
CD81, and CD63) and reorganization of cell surface CD9. Sec-
ond, CD9 is functionally connected to  6 4, consistent with its
physical association. As seen elsewhere, anti-CD9 antibodies
inhibited the motility of cultured keratinocytes under conditions
where motility is at least partially  6 4-dependent (Jones et al.,
1996; Baudoux et al., 2000). Consistent with this, we used an
anti-CD9 antibody to stimulate MDA-MB-435 cell spreading,
which is partly  6 4 dependent, as evidenced by the negative
effects of  4 mutation. It was a little surprising that anti-CD9
antibody also stimulated spreading of MDA-MB-435 cells
bearing mutant  4. However, we note that removal of  4 pal-
mitoylation does not completely dissociate CD151– 6 4 from
CD9 and other tetraspanins. There remain six palmitoylation
sites in CD151, and one site in  6, that likely contribute to con-
tinued CD9 association. Third, an association with TEMs pro-
vides a mechanism to link CD151– 6 4 with several other
molecules known to regulate cell morphology and signaling.
These include other CD9-associated proteins such as EWI-2
(Stipp et al., 2003a; Kolesnikova et al., 2004), PKC (Zhang et
al., 2001), and phosphatidylinositol 4-kinase (Yauch and Hem-
ler, 2000). In this regard, CD9 has also been linked to signaling
of c-kit and EGFR tyrosine kinases (Higashiyama et al., 1995;
Shi et al., 2000; Anzai et al., 2002). It was suggested previously
that CD9 regulation of  6 4 might only be relevant when cells
are migrating and/or when the  6 4 is associated with the actin
cytoskeleton rather than stably interacting with intermediate fil-
aments within hemidesmosome-like structures (Baudoux et al.,
2000). Indeed, tetraspanins CD9 and CD81 are not associated
with the CD151– 6 4 complex in hemidesmosomes (Sterk et
al., 2000), and mutation of  4 palmitoylation sites did not af-
fect hemidesmosome localization, as observed here and by
Gagnoux-Palacios et al. (2003).
Our  4 mutation had minimal effect on cell adhesion to
laminin-1 or laminin-5. This result is consistent with previous
results in which  4 in MDA-MB-435 cells modulated down-
stream signaling but not initial cell adhesion to laminin-1
(Shaw et al., 1997). Furthermore, our  4 mutant was deficient
in spreading and signaling on both laminin-5 and laminin-1,
even though only the former is a very good ligand for  6 4.
Hence, a mechanism is needed to explain how  6 4 can exert
substrate-dependent effects on cell morphology, signaling, and/
or motility, even when it is not primarily responsible for cell
adhesion. In this regard, we have demonstrated that multiple
laminin-binding integrins can be linked together within over-
lapping complexes. Not only were the profiles of palmitoylated
proteins associated with  6 4 and  3 1 strikingly similar, but
also we observed  6 4 and  3 1 coimmunoprecipitations
from multiple cell lines. Hence, we propose that  6 4 can
physically associate with  3 1 (and likely also  6 1), in the
context of TEMs. This provides a mechanism for the close co-
ordination of initial adhesion, mediated by  3 1 (or  6 1),
with subsequent  6 4-dependent spreading, signaling, or mi-
gration. Though novel, these results are not unexpected. It was
previously established that  6 4,  6 1, and  3 1 all can asso-
ciate with CD151 (Berditchevski, 2001), and that CD151 may
appear predominantly as a homodimer (Kovalenko et al., 2004),
thus having the potential to link distinct integrins. Furthermore,
all of these integrins were known to associate with additional
tetraspanins (CD9, CD81, CD63, etc.), which can associate
with each other (Boucheix and Rubinstein, 2001; Berditchevski
et al., 2002; Hemler, 2003).
TEMs and lipid raft localization
Protein palmitoylation can lead to localization into lipid rafts
and decreased solubility in nonionic detergents (Dunphy and
Linder, 1998; Resh, 1999). Indeed, it was suggested else-
where that  4 palmitoylation promotes lipid raft localization,
thus providing a mechanism for bringing  4 into functionally
important complexes with Src family kinases such as fyn and
yes (Mariotti et al., 2001; Gagnoux-Palacios et al., 2003).
However, we found no evidence for palmitoylation promot-
ing either integrin or tetraspanin association with lipid rafts.
First, in  4-transfected A431 cells, the presence of  4 palmi-
toylation was not associated with decreased density in either
Brij 96 or Triton X-100 lysates. Second, neither the palmi-
toylated subset nor the cell surface–labeled subset of endoge-
nous  4 in A431 cells appeared in low density sucrose gradi-
ent fractions, even in mild Brij 96 detergent. Third,  4
palmitoylation did not decrease detergent solubility in MDA-
MB-435 cells. In fact, in a short-term detergent (Brij 96) sol-
ubility assay,  4 palmitoylation increased solubility. Fourth,
our  4 results are in complete agreement with prior results re-
garding tetraspanin palmitoylation. Protein density was not
affected by removal of palmitoylation from either CD151 or
CD9 (Berditchevski et al., 2002; Charrin et al., 2002; Yang et
al., 2002), and CD151 palmitoylation did not decrease deter-
gent solubility (Yang et al., 2002). Fifth, we did not see
changes in association of mutant  4 with signaling proteins
(EGFR, ErbB3/2, and fyn) that can be found in lipid rafts.
Despite the potential of tetraspanins to associate with gangli-
osides and cholesterol, TEMs consistently remain distinct
from lipid rafts. In contrast to lipid rafts, TEMs are resistant
to cholesterol depletion, typically appear in the soluble phase
upon extraction by nonionic detergents, and are not disrupted
at 37 C (Hemler, 2003). An extensive proteomics analysis of
lipid rafts did not reveal any tetraspanins or palmitoylated in-
tegrins (Foster et al., 2003). Conversely, we have identified,
by mass spectrometry, numerous potential partners for tet-
raspanins and palmitoylated integrins, but this list does not
contain typical raft-type proteins such as caveolins and GPI-
linked proteins (unpublished data).
In conclusion, palmitoylation of  4 integrin, as seen pre-
viously for CD151, plays a key role in integrin-dependent cell
spreading and signaling, and in the maintenance of secondary
interactions with additional tetraspanin proteins. We suggest
that CD151– 6 4, CD151– 3 1, and CD151– 6 1 assemble
with other tetraspanins into novel signaling platforms (TEMs).
These provide a framework for the regulation of integrin-de-
pendent postadhesion functions (spreading, signaling, and mo-
tility) and coordination of the functions and distributions of
laminin-binding integrins at the cell–substrate interface.INTEGRIN PALMITOYLATION • YANG ET AL. 1239
Materials and methods
Reagents and cells
mAbs to integrins  2 (A2-IIE10),  3 (A3-X8 and A3IVA5),  6 (A6-ELE); to
tetraspanins CD9 (C9BB and DU-ALL-1), CD63 (6H1), CD81 (M38 and
JS64), CD82 (M104), and CD151 (5C11 and 1A5); and to CD147
(8G6) were referenced previously (Kazarov et al., 2002; Yang et al.,
2002). Other mAbs used were anti–integrin  6 (GoH3; BD Biosciences),
anti- 4 (AA3; provided by V. Quaranta, Vanderbilt University, Nashville,
TN) anti-CD9 (ALB6; CHEMICON International), and anti-CD71 (OKT9;
American Type Culture Collection). Also used were rabbit polyclonal anti-
bodies to  4 and  1 integrins (CHEMICON International) and to the cyto-
plasmic domains of integrins  3A (Dipersio et al., 1995) and  6A (Ab
6843; a gift from V. Quaranta). mAbs to phosphotyrosine (4G10) and PI
3-K p85 were purchased from Upstate Biotechnology, and antibodies to
EGFR, ErbB2, and ErbB3 were purchased from Transduction Laboratories.
Antibodies to FAK, fyn, Src, and p130Cas were obtained from Santa
Cruz Biotechnology, Inc., and anti-GFP was obtained from CLONTECH
Laboratories, Inc.
L-[
35S]methionine/L-[
35S]cysteine and [
3H]palmitic acid were pur-
chased from NEN Life Science Products; brefeldin A (Sigma-Aldrich) was
dissolved in DMSO or ethanol at 1–2 mg/ml and stored at  80 C. EGF
and heregulin- 1 were purchased from Upstate Biotechnology and R&D
Systems, respectively. Sulfo-NHS-LC-Biotin and Sulfo-NHS-SS-Biotin were
obtained from Pierce Chemical Co. PP2, a specific inhibitor for Src family
kinases, was obtained from Calbiochem. Laminin-5 was a gift (Desmos
Inc., San Diego, CA) and vitronectin was purchased from Becton Dickin-
son. Cell lines were grown in DME supplemented with 10% FCS (GIBCO
BRL), 10 mM Hepes, and antibiotics (penicillin and streptomycin). B12 kid-
ney epithelial cells, lacking  3 integrin, were a gift from J. Kreidberg
(Children’s Hospital Boston, Boston, MA; Kreidberg et al., 1996).
Integrin constructs and transfection
Point mutants (C→S) were generated in human  4 or  3 integrin subunits
by PCR and subcloned into pcDNA3.1 (Invitrogen). To generate GFP-
tagged  4, a 2.2-kb NH2-terminal fragment of human  4 was amplified
and subcloned into EGFP-N1 vector via XhoI and EcoRI sites. Additional
 4 fragments (with or without C→S point mutations) were subcloned and
then were inserted via EcoRI and Kpn sites.  4 and  3 sequences were
confirmed by DNA sequencing at the Dana-Farber Cancer Institute core
facility. Lipofectamine (GIBCO BRL) was used for transient and stable
transfections. Human integrin wild-type and mutant   subunits were stably
expressed in the B12 cell line, a murine  3 integrin-null kidney epithelial
cell line (Wang et al., 1999), using the Fugene 6 method (Roche Diagnos-
tics Corporation). Integrin mutant X3TC5 is an  3 subunit with the trans-
membrane domain and cytoplasmic tail replaced by corresponding do-
mains from  5 (Yauch et al., 1998).
Protein labeling, immunoprecipitation, and immunoblotting
For [
3H]palmitate labeling, cell lines (at 80–90% confluence) were
washed twice in PBS, serum-starved for 3–4 h, and then pulsed for 1–2 h
in medium containing 0.2–0.3 mCi/ml [
3H]palmitic acid plus 5% dia-
lyzed FBS. For surface labeling with biotin, semiconfluent cells were
cooled on ice, washed three times in PBS, incubated in PBS containing
Sulfo-NHS-LC-Biotin at 0.1–0.2 mg/ml for 1 h at 4 C, and then washed
with cold PBS containing 0.1 M glycine. Labeled cells were lysed in RIPA
(1% Triton X-100, 1% deoxycholate, and 0.1% SDS) or in buffer contain-
ing 1% Brij 96 for 1 h at 4 C. Immunoprecipitation, immunoblotting, and
detection of [
3H]palmitate were described previously (Yang et al., 2002).
Immunofluorescence microscopy and flow cytometry
A431 cells were cultured overnight on 60-mm dishes with coverglass bot-
toms (MaTek Corp.). Cells were then transfected with GFP-tagged  4 con-
structs, and after 48 h were rinsed in PBS and photographed (Axioskop;
Carl Zeiss MicroImaging, Inc.) at a magnification of 100. For flow cytom-
etry (FACSCalibur; Becton Dickinson), stably transfected semiconfluent
MDA-MB-435 cells were detached and stained on ice with either control
IgG or specific mAbs, followed by FITC-conjugated secondary antibody
(Biosource International).
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